CYPRIUM PARTNERS
CYPRIUM PARTNERS is a Series C+, buyout, debt and other fund in the US and Canada writing $5M–$60M checks into Healthcare, manufacturing, distribution, business-services, food-and-beverage, technology-enabled, aerospace, agriculture-products, automotive, building-products and plastics-and-packaging.
- Stages
- Series C+, buyout, debt, other
- Sectors
- Healthcare, manufacturing, distribution, business-services, food-and-beverage, technology-enabled, aerospace, agriculture-products, automotive, building-products, plastics-and-packaging
- Check size
- $5M–$60M
- Invests in
- US-wide, Canada
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 1998
- Assets under management
- $1B+
Thesis
Cyprium Partners is a private equity and mezzanine firm focused on making non-control investments in profitable, middle-market companies in the United States and Canada. They target companies with minimum EBITDA of $4 million, sales between $20 million and $300 million, and predictable cash flow. Cyprium has a broad industry focus, including manufacturing, distribution, business services, food and beverage, healthcare, technology-enabled companies, and more. They lead investments ranging from $5 million to $60 million. The firm was founded in 1998 and is headquartered in Cleveland, Ohio. As of December 31, 2025, they managed approximately $760.2 million in client assets. They have a diverse portfolio with over 100 platform investments.
Common questions
Does CYPRIUM PARTNERS invest at the Series C+ stage?
Yes. CYPRIUM PARTNERS lists Series C+, buyout, debt and other among the stages it invests in.
What check size does CYPRIUM PARTNERS write?
CYPRIUM PARTNERS writes $5M–$60M checks.
Where does CYPRIUM PARTNERS invest?
CYPRIUM PARTNERS invests in the US and Canada.